Kivu Bioscience

Series-A
kivubioscience.com Biotech & Healthcare San Francisco, United States 11-50
Total Funding $92M
Latest Round $92M Series-A
Last Announced Oct 28, 2024
Investors 7 Backers
Decision Makers 6 Verified

About Kivu Bioscience

At Kivu Bioscience, we leverage advanced, next-generation proprietary ADC technologies to deliver more precise and effective cancer treatments.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-A
Global Headquarters San Francisco, United States
Team Size 11-50
Tracked Since Oct 1, 2026

Web & Domain Identity

Official Website kivubioscience.com
Domain Registered Date Jun 22, 2023

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Raised $92,000,000 · Series-A

    fundraisingfox.com

  2. Milestone

    Website domain registered

    kivubioscience.com

Investors & Backers

7
BioGeneration Ventures
BOM
Gimv
HealthCap
M Ventures
Novo Holdings
Red Tree Venture Capital

Funding History

1 Round
Series-A · Oct 28, 2024

Founders & Leadership

5

Ann MacLaren

SVP and Head of Translational Medicine

Work email & phone locked Unlock →

Brunilda Shtylla

Chief Business Officer

Work email & phone locked Unlock →

Liangyi Zhang

VP & Head of CMC

Work email & phone locked Unlock →

Mohit Trikha

President & COO

Work email & phone locked Unlock →

Sophia Randolph

Chief Medical Officer

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts